PARADOXICALLY ELEVATED LEVELS OF TUMOUR NECROSIS FACTOR IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS ON ETANERCEPT

被引：0
|
作者：
Fisher, Corinne [1 ,2 ]
Suffield, Linda [1 ,2 ]
Radziszewska, Ania [1 ,2 ]
Hanns, Laura [1 ,2 ]
Sen, Debajit [1 ,2 ]
Ioannou, Yiannis [1 ,2 ,3 ]
机构：
[1] UCL, Arthrit Res UK Ctr Adolescent Rheumatol, London, England
[2] Great Ormond St Hosp Sick Children, London, England
[3] Univ Coll London Hosp, Natl Inst Hlth Res, Biomed Res Ctr, London, England
来源：
RHEUMATOLOGY | 2014年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
295
引用
收藏
页码：170 / 170
页数：1
相关论文
共 50 条
  • [41] Ghrelin levels in patients with juvenile idiopathic arthritis: relation to anti-tumor necrosis factor treatment and disease activity
    Karagiozoglou-Lampoudi, Thomais
    Trachana, Maria
    Agakidis, Charalampos
    Pratsidou-Gertsi, Polyxeni
    Taparkou, Anna
    Lampoudi, Sotiria
    Kanakoudi-Tsakalidou, Florentia
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2011, 60 (10): : 1359 - 1362
  • [42] Genotoxicity of Anti-Tumor Necrosis Factor Therapy in Patients With Juvenile Idiopathic Arthritis
    Demirkaya, Erkan
    Cok, Ismet
    Durmaz, Emre
    Ulutas, Onur K.
    Ayaz, Nuray Aktay
    Besbas, Nesrin
    Ozen, Seza
    ARTHRITIS CARE & RESEARCH, 2010, 62 (01) : 73 - 77
  • [43] Use of infliximab in patients with systemic juvenile idiopathic arthritis refractory to etanercept
    Katsicas, MM
    Russo, RAG
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (04) : 545 - 548
  • [44] Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and/or infliximab
    María M. Katsicas
    Ricardo A. G. Russo
    Clinical Rheumatology, 2009, 28 : 985 - 988
  • [45] Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and infliximab
    Katsicas, M. M.
    Russo, R. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 551 - 552
  • [46] Etanercept in patients with juvenile idiopathic arthritis: Results of a retrospective multicenter registry
    Calvo, I.
    Lopez, B.
    Merino, R.
    Garcia-Consuegra, J.
    Moreno, P.
    Lacruz, L.
    Bravos, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 440 - 440
  • [47] Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and/or infliximab
    Katsicas, Maria M.
    Russo, Ricardo A. G.
    CLINICAL RHEUMATOLOGY, 2009, 28 (08) : 985 - 988
  • [48] Delayed Clinical Response in Patients with Juvenile Idiopathic Arthritis Treated with Etanercept
    Otten, Marieke H.
    Prince, Femke H. M.
    Twilt, Marinka
    van Rossum, Marion A. J.
    Armbrust, Wineke
    Hoppenreijs, Esther P. A. H.
    Kamphuis, Sylvia
    Koopman-Keemink, Yvonne
    Wulffraat, Nico M.
    Gorter, Simone L.
    ten Cate, Rebecca
    van Suijlekom-Smit, Lisette W. A.
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (03) : 665 - 667
  • [49] Discontinuation of etanercept after successful treatment in patients with juvenile idiopathic arthritis
    Remesal, A.
    Casado, R.
    Merino, R.
    De Inocencio, J.
    Garcia-Consuegra, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 420 - 420
  • [50] Discontinuation of etanercept after clinical remission in patients with juvenile idiopathic arthritis
    Jean-David Cohen
    Dominique Fournet
    Catherine Ludwig
    Marie-Cécile Bozonnat
    Michel Rodiere
    Christian Jorgensen
    Pediatric Rheumatology, 10 (Suppl 1)
12345